3-year survival rate in acute lymphoblastic leukemia: comparison of ALL-2006 and ALL-2013 Protocols
Background With advances in supportive and risk-stratified therapy, the 5-year survival rate of acute lymphoblastic leukemia has reached 85.5%. The ALL-2006 treatment protocol was modified and renamed the ALL-2013 protocol, with dose and duration changes. Objective To compare outcomes of the ALL-200...
Saved in:
Main Authors: | Avyandita Meirizkia (Author), Dewi Rosariah Ayu (Author), Raden Muhammad Indra (Author), Dian Puspita Sari (Author) |
---|---|
Format: | Book |
Published: |
Indonesian Pediatric Society Publishing House,
2021-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cost-utility of Protocols of BFM-ALL and UK-ALL for Treatment of Children with Acute Lymphoblastic Leukemia in Iran
by: Hadi HAYATI, et al.
Published: (2018) -
Dermatological toxicity of acute lymphoblastic leukemia treatment by protocol ALL IC-BFM 2002
by: Timur T. Valiev, et al.
Published: (2022) -
Shorter maintenance therapy in childhood Acute Lymphoblastic Leukemia. The experience of the prospective, randomized Brazilian GBTLI ALL-93 protocol.
by: Silvia Regina Brandalise, et al.
Published: (2016) -
Treatment methods for patients suffering from acute lymphoblastic leukemia (all) - a brief review
by: Zuzanna Czudy, et al.
Published: (2023) -
Costs associated with adverse events from remission induction for children with Acute Lymphoblastic Leukemia (ALL)
by: Eréndira Mejía-Aranguré, et al.
Published: (2022)